| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2771181 | Seminars in Anesthesia, Perioperative Medicine and Pain | 2007 | 7 Pages |
Abstract
Malignant hyperthermia (MH) is a pharmacogenetic clinical syndrome that occurs in patients with preexisting abnormal skeletal muscle. It manifests clinically as a hypermetabolic crisis when a MH-susceptible individual is exposed to an inhalational anesthetic or a depolarizing muscle relaxant (ie, succinylcholine).
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ronald S. Litman,